A Phase 1/2, Open-Label Clinical Study to Evaluate Safety, Tolerability, and Efficacy of NGN-401 in Pediatric Subjects with Rett Syndrome This study will evaluate the safety profile of the investigational gene therapy, NGN-401, in female children with typical Rett syndrome. Start Date13 Jun 20...